FDA Inspection 1007875 — Bausch & Lomb Incorporated

Bausch & Lomb Incorporated — FEI 1317628

The FDA completed an inspection of Bausch & Lomb Incorporated on March 24, 2017 in Rochester, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, NY (United States)

Citations

IDCFRDescription
312821 CFR 820.90(a)Nonconforming product control
435321 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs